News

Nanobiotix got the all-clear for its new Phase I/II clinical trial


TRY IT NOW

Sign up online today & collaborate

or click here to find out more

Nanobiotix got the all-clear for its new Phase I/II clinical trial


Date: 03/07/2015


The French National Agency for Medicines and Health Products gave Nanobiotix the green light to start a Phase I/II trial in two new cancer populations for its lead product, NBTXR3. This could lead to an increase in the commercial potential of this promising French Biotech.

Nanobiotix is a great French Biotech company, which you can discover better in our exclusive interview of its charismatic CEO Laurent Levy.

For more click here

Source: Labiotech

© Catalyst Innovation Portal 2019